- Business
- FIGX Capital Acquisition Corp. is a blank check company incorporated in the Cayman Islands that focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses, primarily targeting the financial industry group (FIG) sector; it concentrates efforts on differentiated private wealth and asset managers positioned to become integrated multi-asset fund managers with diversified distribution channels and global market presence, while remaining open to opportunities across the broader FIG ecosystem including alternatives, fintech, specialty finance, insurers, financial information services, fund administrators, IT/AI solutions for fund managers, and investor consultancy. The company offers no current products or services beyond its SPAC structure, which includes publicly traded units (FIGXU) comprising one Class A ordinary share and one-half of a redeemable warrant (exercisable at $11.50), with separated Class A ordinary shares (FIGX) and warrants (FIGXW) commencing trading on August 18, 2025; it maintains a trust account holding proceeds from its initial public offering and private placements invested in U.S. Treasury obligations. Founded in 2025 and headquartered at 428 Greenwood Beach Road, Tiburon, California, FIGX Capital Acquisition Corp. operates with a 24-month period to complete a business combination (expiring June 30, 2027) and targets investors seeking exposure to financial sector consolidation without current revenue generation or employees. In June 2025, the company completed an oversubscribed initial public offering of 15,065,000 units at $10.00 each, raising gross proceeds of $150.65 million including the full exercise of the over-allotment option, alongside a simultaneous private placement of 443,470 units for $4.43 million to its sponsor and Cantor Fitzgerald; units began trading on Nasdaq under FIGXU on June 27, 2025, with 100% of IPO proceeds placed in trust. More recently, on November 12, 2025, board member Dr. Russel Read resigned from the board and audit committee, reflecting ongoing governance adjustments as the company remains in pre-deal status with no merger target announced.